World Health Assembly: PM Modi highlights India's contributions to global health initiatives in Geneva
PM Modi mentioned India's Ayushman Bharat scheme, the world's largest health insurance program, which covers 580 million people and provides free treatment.
He outlined three cores for the future of a healthy world -- inclusion, integrated vision and collaboration.
'The future of a healthy world depends on inclusion, integrated vision and collaboration. Inclusion is at the core of India's health reforms. We run Ayushman Bharat - the world's largest health insurance scheme. It covers 580 million people and provides free treatment. This program was recently extended to cover all Indians above 70 years,' said PM Modi.
He emphasised India's network of health and wellness centres, which screen and detect diseases like cancer, diabetes, and hypertension.
'We have a network of thousands of health and wellness centres. They screen and detect diseases such as cancer, diabetes and hypertension. Thousands of public pharmacists provide high-quality medicines at far less than the market price,' added PM Modi.
PM Modi invited countries to participate in the International Day of Yoga, with the theme 'Yoga for One Earth One Health.'
'In June, the 11th International Day of Yoga is coming up. This year's theme is 'Yoga for One Earth One Health.' Being from the nation that gave yoga to the world, I invite all countries to participate,' said PM Modi.
PM Modi congratulated the WHO and member states on the successful negotiations of the INB Treaty, aimed at fighting future pandemics with greater cooperation.
'I congratulate the WHO and all Member States on the successful negotiations of the INB Treaty. It is a shared commitment to fight future pandemics with greater cooperation while building a healthy planet. Let us ensure that no one is left behind,' he said.
The INB was established in December 2021, at a special session of the World Health Assembly, bringing together Member States and relevant stakeholders, including international organizations, private sector, and civil society.
At the World Health Assembly in June 2024, governments made concrete commitments to complete negotiations on a global pandemic agreement within a year. The upcoming Assembly, starting May 19, 2025, will consider the proposal developed by the INB and decide whether to adopt the instrument under Article 19 of the WHO Constitution.
PM Modi also highlighted India's digital health initiatives, including a platform to track vaccination and a telemedicine service enabling over 340 million consultations.
'Technology is an important catalyst to improve health outcomes. We have a digital platform to track the vaccination of pregnant women and children. Millions of people have a unique digital health identity. It helps us integrate benefits, insurance, records, and information. With telemedicine, nobody is too far from a doctor. Our free telemedicine service has enabled over 340 million consultations,' he added.
PM Modi offered to share India's learnings and best practices with the Global South, particularly in addressing health challenges.
'The health of the world depends on how well we care for the most vulnerable. The Global South is particularly impacted by health challenges. India's approach offers replicable, scalable and sustainable models. We would be happy to share our learnings and best practices with the world, especially the Global South,' he added.
PM Modi also highlighted that India's initiatives have brought down the out-of-pocket expenditure as a percentage of total health expenditure significantly, while government health expenditure has gone up considerably.
'Thousands of public pharmacies across the country provide high-quality medicines at prices significantly lower than market rates, increasing access to essential drugs for all,' he added.
He concluded his speech with a verse from the Vedas, calling for universal well-being: Sarwey bhawantu sukhin sarwey santu niramaya. Sarwey bhadrani pasyantu maa kashichit dukhbhag bahavate (May all be happy, may all be free from illness, may all see what is auspicious, may no one suffer).
Apart from this, after India was conferred the certificate of elimination of Trachoma as a public health problem at the 78th World Health Assembly in Geneva, Union Health Minister JP Nadda lauded this achievement and said it was a proud moment for the nation.
In a post on X, JP Nadda said, 'A proud moment for the nation at WHA78 (World Health Assembly) India has been conferred the Certificate of Elimination of Trachoma as a Public Health Problem by Tedros Adhanom Ghebreyesus, Director-General at WHO, at the 78th World Health Assembly in Geneva.' (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
3 hours ago
- The Hindu
How technology can help ease dementia diagnosis and care burden in India
Dementia is a growing problem, particularly in a country like India, which has a rapidly ageing population. Awareness, diagnosis and access to care however, continue to remain limited. Can digital and assistive technologies help? Researchers and doctors say there is a lot of potential, but the challenge is, in making them affordable for patients. The burden According to the World Health Organization (WHO), over 55 million people worldwide live with dementia, with nearly 10 million new cases added annually. Alzheimer's disease is the most common form, contributing to 60–70% of cases. Low- and middle-income countries, including India, bear the greatest burden, with dementia prevalence expected to triple by 2050 due to demographic ageing. Emerging technologies 'In India, assistive and digital technologies are emerging as force multipliers,' said Prabash Prabhakaran, director and senior consultant, neurology, SIMS Hospital, Chennai. These range from GPS trackers and low-cost Internet of Things (IoT) wearables for patients who wander or leave their designated areas, to home sensors that monitor movement, appliance usage, or medication adherence. Smartwatches and wearable devices for activity, sleep and fall detection are becoming more common, while smartphone-based cognitive screening apps and gamified brain-training tools are in validation stages. Virtual reality modules are also being piloted, designed in vernacular languages and Indian cultural settings for reminiscence therapy and navigation training. At the research frontier, Indian centres are developing blood-based biomarker panels for early Alzheimer's detection, alongside AI-driven multimodal digital biomarkers that combine gait, speech, typing patterns and passive smartphone signals. 'Earlier and scalable detection is becoming possible because smartphone penetration is high, even among older households,' Dr. Prabhakaran explained. Studies have shown that keystroke dynamics, speech analysis and passive phone use can serve as unobtrusive early-warning signals. Sindhuja L., consultant neurophysician at V.S. Hospitals, Chennai, said AI now picks up subtle changes 'in brain scans, speech or even handwriting that escape the human eye.' She noted that digital biomarkers such as walking speed and reaction time are being captured on tablets and smartphones, even by mobile health units visiting rural communities. Dr. Prabhakaran stressed that these technologies are not replacements for clinical diagnosis, but 'powerful early detection and monitoring tools, especially valuable in India where clinic-based testing is episodic.' Easing caregiver stress 'Dementia disrupts daily living, independence, and safety while burdening caregivers. Assistive technologies help maintain independence and reduce stress,' Dr. Prabhakaran said. In practice, families are using GPS trackers, pill-box alarms, fall detectors, and voice-assisted reminders. Smart-home solutions, such as motion-triggered lights and automatic stove shut-offs, are now feasible in urban settings. Therapeutic tools also show promise. Virtual reality reminiscence therapy has allowed patients to revisit festivals or familiar neighbourhoods, sparking positive memories. 'When families join in brain-training games in local languages, they turn into a shared, engaging activity instead of a medical routine,' Dr. Sindhuja said. Gaps and digital-first solutions Nearly two-thirds of India's older adults live in rural areas, where dementia specialists are scarce. 'Travel distance, cost, stigma, and shortage of trained specialists mean many cases remain undiagnosed or untreated,' Dr. Prabhakaran said. Here, telemedicine, remote monitoring, and community-driven digital platforms offer a bridge. Accredited frontline health workers can use smartphone screening apps, while caregivers rely on WhatsApp-based peer groups for emotional and practical support. Dr. Sindhuja emphasised that 'scheduled video calls or remote monitoring can catch problems before they escalate, making care less isolating.' High costs, lack of insurance, and uneven after-sales support remain critical hurdles. 'Most advanced devices are imported and unaffordable for average families,' said Dr. Sindhuja. In rural areas, poor connectivity worsens access. Cultural barriers also persist, as memory loss is still seen as part of normal ageing, leading to delayed care-seeking. Considering these challenges, Sridhar Vaitheeswaran, consultant psychiatrist and the head of DEMCARES (Dementia Care in SCARF) at the Schizophrenia Research Foundation (SCARF) in Chennai, said the Foundation, in collaboration with Imperial College London, has been working on technologies like the humanoid robot to assist people living with dementia, offering companionship and cognitive support. SCARF is also developing virtual reality services and using platforms such as Zoom to help patients connect with their families. The aim is to improve these tools and create more seamless ways for people with dementia to stay engaged and supported. Need for subsidies Dr. Prabhakaran called for policy interventions including subsidies, insurance inclusion, and local-language adaptation. He proposed 'digital dementia corners' at primary health centres, equipped with tablets, VR stations, and screening kiosks. Doctors emphasised the need for public–private partnerships to localise production, ensure affordability, and drive awareness campaigns in regional languages. Towards a national dementia-tech ecosystem A wide range of assistive technologies is used globally-- In Japan, scannable QR codes and wearable barcodes are widely used to help locate individuals who wander. The U.K. promotes the use of reminder clocks, smart home sensors and medication dispensers through the National Health Services and dementia charities. In the U.S., devices like AngelSense integrate GPS tracking, two-way communication and fall detection, offering comprehensive monitoring. Australia supports telecare systems and simplified tablets for memory and social engagement. Sweden and the Netherlands are pioneers in using smart homes and robotic companions for dementia care, incorporating AI and ambient monitoring. These innovations, however, remain out of reach for most Indian families. The challenge, experts argue, is not just scientific but systemic, ensuring that validated, affordable, culturally relevant technologies reach homes across India. The path forward lies in scalable, inclusive technology, integrated with grassroots healthcare and caregiver networks. As Dr. Prabhakaran explained, 'Assistive devices, GPS trackers, smart-home solutions, and therapeutic tools are not luxuries: they are critical enablers of safer, more independent living. With proper validation, affordability, and integration into national elder-care programmes, these technologies can transform dementia care in the coming decade.'
Time of India
4 hours ago
- Time of India
Palestinian Health Ministry says more than 62,000 Palestinians have been killed in Gaza war
The Palestinian Health Ministry said on Monday that more than 62,000 Palestinians have been killed in the 22-month Gaza war . Independence Day 2025 Modi signals new push for tech independence with local chips Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji Subhas Chandra Bose gave India its own currency At least 60 people were killed in the past 24 hours, bringing the death toll from the Israel-Hamas war that started on Oct. 7, 2023 to 62,004. Another 156,230 have been wounded, it said. The Health Ministry said 1,965 people were killed while seeking aid from aid convoys or killed close to aid distribution sites. At least seven Palestinians were killed attempting to access aid on Monday morning. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like SRM Online MBA – Empowering Future Leaders SRM Online Enquire Now Undo The ministry, which doesn't distinguish between civilians and combatants in its count, is staffed by medical professionals. The United Nations and other independent experts view its figures as the most reliable count of casualties. Israel has disputed its figures, but hasn't provided its own account of casualties.
Time of India
4 hours ago
- Time of India
Glenmark, Alembic Pharma, Sun Pharma recall products in US: USFDA
Drug makers Glenmark , Alembic Pharmaceuticals and Sun Pharma are recalling products in the US due to manufacturing issues, according to the US health regulator. Independence Day 2025 Modi signals new push for tech independence with local chips Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji Subhas Chandra Bose gave India its own currency Mumbai-based Glenmark is recalling two products in the market, the US Food and Drug Administration ( USFDA ) said in its latest Enforcement Report. Glenmark Pharmaceuticals Inc, USA, a subsidiary of the company, is recalling Carvedilol tablets, used to treat heart failure, hypertension, and heart attack, in multiple strengths. The New Jersey-based firm is recalling 55,560 units of the affected lot due to "presence of a nitrosamine, N-Nitroso Carvedilol impurity above the current acceptable intake level," the USFDA stated. The company is also recalling 17,496 bottles of Carvedilol tablets as "results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm," it added. Live Events Glenmark initiated the Class II recall in August this year. USFDA said the company is also recalling 22,656 bottles of Theophylline extended-release tablets (400 mg) for failed dissolution specifications. Alembic Pharmaceuticals is recalling 9,492 bottles of Doxepin Hydrochloride capsules, used in the treatment of insomnia, the US health regulator stated. The Class II recall is due to the "Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit," it said. The company initiated the recall on July 25 this year. New Jersey-based Sun Pharmaceutical Industries Inc is recalling 11,328 bottles of Spironolactone Tablets, used to treat high blood pressure, due to "Presence of foreign substance: identified as aluminum," the regulator said. The company commenced the Class II recall on August 5. As per the USFDA, a Class-II recall is initiated when the use of, or exposure to, a violative product may lead to temporary or medically reversible health consequences, or when the likelihood of serious adverse health outcomes is minimal.
